PACB - Latest News
Pacific Biosciences of California, Inc. (PACB), operates in Healthcare / Medical - Devices, trades on NASDAQ.
Market capitalization stands near $512.5M. Beta to the broader market is 2.32.
The article list below shows the most recent PACB headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent PACB Headlines
Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: Here's Why
zacks.com - Jun 30, 2026
Pacific Biosciences of California (PACB) closed at $1. 68 in the latest trading session, marking a -2.
Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: Here's Why
zacks.com - Jun 12, 2026
Pacific Biosciences of California (PACB) closed the most recent trading day at $1. 31, moving 2.
Here's Why You Should Add PacBio Stock to Your Portfolio Now
zacks.com - Jun 3, 2026
PACB's growth is supported by HiFi sequencing advances and product momentum, though funding pressures weigh on instrument demand.
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026
zacks.com - Jun 2, 2026
Genomics and synthetic biology are reshaping healthcare, with growing demand for precision medicine spotlighting stocks like PACB, MYGN and TWST.
PacBio Expands HiFi Sequencing Reach With New SPRQ-Nx Technology
zacks.com - Jun 1, 2026
PACB expands HiFi sequencing reach with commercial availability of SPRQ-Nx for Revio, lowering costs by about 30% and adding AI and epigenetics upgrad
How News Affects PACB Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track PACB's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked PACB news questions
- What is the latest PACB news headline?
- The most recent PACB headline (Jun 30, 2026) is "Pacific Biosciences of California (PACB) Stock Sinks As Market Gains: Here's Why". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the PACB news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What PACB news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual PACB options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.